VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Ambev S.A. vs Edwards Lifesciences Corporation
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Ambev S.A.
ABEV3 · B3 - Brasil Bolsa Balcao
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Ambev S.A.'s moat claims, evidence, and risks.
View ABEV3 analysisEdwards Lifesciences Corporation
EW · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Edwards Lifesciences Corporation's moat claims, evidence, and risks.
View EW analysisComparison highlights
- Moat score: both at 82 / 100.
- Segment focus: Ambev S.A. has 5 segments (45% in Brazil - Beer); Edwards Lifesciences Corporation has 3 segments (75.5% in Transcatheter Aortic Valve Replacement (TAVR)).
- Moat breadth: Ambev S.A. has 3 moat types across 3 domains; Edwards Lifesciences Corporation has 6 across 3.
Primary market context
Ambev S.A.
Brazil - Beer
Beer production and distribution
Brazil
On-trade and off-trade retailers; distributors
Producer & distributor
45%
Edwards Lifesciences Corporation
Transcatheter Aortic Valve Replacement (TAVR)
Transcatheter aortic valve replacement (TAVR) devices
Global
Hospitals and structural heart centers
Medical device manufacturer
75.5%
Side-by-side metrics
Moat coverage
Shared moat types
Ambev S.A. strengths
Edwards Lifesciences Corporation strengths
Segment mix
Ambev S.A. segments
Full profile >Brazil - Beer
Oligopoly
Brazil - Non-alcoholic beverages
Oligopoly
Central America and the Caribbean
Oligopoly
Latin America South
Oligopoly
Canada
Oligopoly
Edwards Lifesciences Corporation segments
Full profile >Transcatheter Aortic Valve Replacement (TAVR)
Oligopoly
Transcatheter Mitral and Tricuspid Therapies (TMTT)
Competitive
Surgical Structural Heart
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.